Efforts to expand the Air Force’s software development environment, Platform One, have stalled after some senior military IT leaders raised cybersecurity concerns about the platform, FedScoop has ...

Dyne Therapeutics Inc. is advancing novel therapeutics for people living with genetically driven neuromuscular diseases. Representatives from the company recently presented a poster showcasing ...

Dyne Therapeutics Inc. presented their most recent work to advance novel therapeutics for facioscapulohumeral muscular dystrophy (FHSD). FSHD is an autosomal dominant genetic disorder characterized by ...

FAIRFAX, Va.--(BUSINESS WIRE)--ECS, a leader in advanced technology, science, and engineering solutions, has been selected as an authorized reseller of U.S. Air Force (USAF) Platform One (P1) products ...